PUBLICATIONS

Muvon

First in Human trial results published, demonstrating safety and feasibility of MUVON's SUI Therapy

First in Human (FIH) trial results of MUVON's regenerative therapy for the treatment of stress urinary incontinence are now officially...

Muvon

Translation and automation hurdles for cell therapies

Informative article published in BioInsights, written by our CSO Jenny Prange and our innovation manager Beatrix Rauch Schmid. This...

Muvon

Modern Therapy of Urinary Incontinence Using Muscle Stem Cells (Article in German)

Abstract: Urinary incontinence affects a large number of patients, and the cost of treatment continues to rise with the demographic...

Muvon

Muscle Precursor Cells for the Restoration of Irreversibly Damaged Sphincter Function

Abstract Multiple modalities, including injectable bulking agents and surgery, have been used to treat stress urinary incontinence....

Muvon

The role of donor age and gender in the success of human muscle precursor cell transplantation

Abstract Autologous cell transplantation for the treatment of muscle damage is envisioned to involve the application of muscle precursor...